封面
市场调查报告书
商品编码
1516051

血清分离凝胶市场 - 副产品(不含整合管的血清分离凝胶、整合管的血清分离凝胶)、最终用途(医院、血库、製药公司) - 全球预测(2024 - 2032)

Serum Separation Gel Market - By Product (Serum Separation Gel Without Integrated Tubes, Serum Separation Gel with Integrated Tubes), End-use (Hospitals, Blood Banks, Pharmaceutical Companies)- Global Forecast (2024 - 2032)

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年至 2032 年,全球血清分离凝胶市场的复合年增长率将达到 5.9%,这主要是由领先公司的产品扩张所推动的。这些扩展是为了满足医学实验室对高效、可靠的诊断工具日益增长的需求。血清分离胶对血液分离的精密度和准确性起着重要作用,这对于诊断测试很重要。例如,2023 年 8 月,Osoh Corporation 宣布计划在其位于山口县周南的分离精炼厂推广 TOYOPEARL-TSKgel PW 业务。这项决定是为了响应日益增长的净化需求。

该公司正在大力投资先进製造设施和新技术,以提高效率并满足不断增长的全球需求。此外,慢性病盛行率的不断上升以及定期健康检查的需求进一步支撑了市场需求。因此,在领先的技术进步和战略基础设施的支持下,血清分离凝胶市场有望强劲成长。

血清分离凝胶产业的整体规模根据产品、最终用途和地区进行分类。

由于临床研究环境中对简单、经济高效的解决方案的需求,整合无管血清分离凝胶细分市场将从 2024 年到 2032 年强劲成长。此外,诊断工作中对分析准确性和建模效率日益增长的需求也促进了这项需求。因此,製造商专注于在不使用整合设备的情况下提高血清分离凝胶的品质和可用性。

製药公司领域的血清分离凝胶市场份额从2024 年到2032 年将出现显着的复合年增长率。的分析方面发挥的关键作用。製药公司需要高品质的凝胶萃取,以确保样品的均质性和一致性。此外,对个人化医疗的日益关注和慢性病的兴起进一步刺激了这种需求。因此,製造商正在增加产量以满足製药行业的需求,从而导致市场成长。

2024年至2032年,欧洲市场的血清分离凝胶市场将呈现合理的复合年增长率。此外,对可靠的血小板分离产品的需求推动了对新医疗技术的需求。此外,严格的法规正在刺激整个地区的市场需求。製造商正在扩大生产并集中生产以满足不断增长的需求,确保欧洲市场的持续成长。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 诊断测试需求不断成长
      • 血液采集技术不断进步
      • 慢性病盛行率上升
      • 越来越多地采用现场护理测试
    • 产业陷阱与挑战
      • 血清分离胶管成本高
      • 遵守监管要求
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:按产品分类,2021 - 2032 年

  • 主要趋势
  • 不含集成管的血清分离凝胶
  • 带有集成管的血清分离凝胶

第 6 章:市场估计与预测:按最终用途分类,2021 - 2032 年

  • 主要趋势
  • 医院
  • 血库
  • 製药公司
  • 其他最终用户

第 7 章:市场估计与预测:按地区划分,2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 8 章:公司简介

  • Becton, Dickinson and Company
  • BIOSIGMA S.p.A.
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • Danaher Corporation
  • FL MEDICAL s.r.l.
  • Greiner AG
  • InterVacTechnology
  • Qiagen N.V.
  • Sekisui Chemical CO., LTD.
简介目录
Product Code: 8814

Global Serum Separation Gel Market will observe a CAGR of 5.9% from 2024 to 2032, primarily driven by product expansion from leading companies. These expansions are a response to the growing need for efficient and reliable diagnostic tools in medical laboratories. Serum separation gel plays an important role in the precision and accuracy of blood separation, which is important for diagnostic tests. For example, in August 2023, Osoh Corporation announced the planned dissemination of TOYOPEARL-TSKgel PW operations at their separation refinery located in Shunan, Yamaguchi Prefecture. This decision is in response to the increasing demand for purification.

Companies are investing heavily in advanced manufacturing facilities and new technologies to improve efficiency and meet growing global demand. In addition, the growing prevalence of chronic diseases and the need for regular health check-ups further support the market demand. As a result, the serum isolation gel market is poised for strong growth, supported by leading-edge technological advances and strategic infrastructure.

The overall Serum Separation Gel industry size is classified based on product, end-use application, and region.

The integrated tubeless serum isolation gel segment will grow robustly from 2024 to 2032, driven by the need for simple, cost-effective solutions in clinical research environments. Furthermore, the increasing demand for analytical accuracy and modeling efficiency in diagnostics efforts contributes to this demand. Consequently, manufacturers are focused on increasing the quality and availability of serum separation gels without the use of integrated devices.

The serum separation gel market share from the pharmaceutical company segment will register a notable CAGR from 2024 to 2032. This growth is attributed to the key role this gel plays in blood purification and providing accurate and reliable analysis for essential drug development and clinical trials. Pharmaceutical companies require high-quality gel extraction to ensure sample homogeneity and consistency. In addition, the expanding focus on personalized medicine and the rise of chronic diseases further encourage this demand. Consequently, manufacturers are increasing production to meet the needs of the pharmaceutical industry, leading to market growth.

Serum isolation gel market from the European segment will exhibit a reasonable CAGR from 2024 to 2032. This is due to the rapidly improving healthcare infrastructure in the region, along with the increasing incidence of chronic diseases requiring daily monitoring. Moreover, the need for reliable platelet isolation products drives the demand for new medical technologies. Additionally, stringent regulations are fueling the market demand across the region. Manufacturers are expanding production and centralizing production to meet this growing demand, ensuring continued market growth in Europe.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising demand for diagnostic testing
      • 3.2.1.2 Growing technological advancement in blood collection
      • 3.2.1.3 Rising prevalence of chronic diseases
      • 3.2.1.4 Growing adoption of point-of-care testing
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of serum separation gel tubes
      • 3.2.2.2 Compliance with regulatory requirements
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Serum separation gel without integrated tubes
  • 5.3 Serum separation gel with integrated tubes

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Blood banks
  • 6.4 Pharmaceutical companies
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Becton, Dickinson and Company
  • 8.2 BIOSIGMA S.p.A.
  • 8.3 Bio-Rad Laboratories, Inc.
  • 8.4 Cardinal Health, Inc.
  • 8.5 Danaher Corporation
  • 8.6 FL MEDICAL s.r.l.
  • 8.7 Greiner AG
  • 8.8 InterVacTechnology
  • 8.9 Qiagen N.V.
  • 8.10 Sekisui Chemical CO., LTD.